STING1 and neoplasm: PC7A can therefore be used in combinationwith 2′-3′ cGAMP or other small molecule STING agonistsfor dual STING-targeted therapy, and the polymer was demonstratedto have robust efficacy for the treatment of multiple tumor models(Figure 3).